▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Rafael (NYSE: RFL)

$2.07

(-5.9%)

-$0.13

Price as of June 13, 2025, 4:00 p.m. ET

Rafael Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
RFL	+39.86%	-85.24%	-31.76%	-57%
S&P	+10.00%	+96.53%	+14.45%	+129%

Rafael Company Info

Rafael Holdings, Inc. owns interest in commercial real estate assets and clinical stage pharmaceutical companies. It operates through the Real Estate and Pharmaceuticals segments. The Real Estate segment refers to the real estate holdings. The Pharmaceuticals segment is comprised of debt interests and warrants in Rafael Pharmaceuticals and a majority equity interest in LipoMedix Pharmaceuticals. The company was founded in 2017 and is headquartered in Newark, NJ.

News & Analysis

Featured Article

Here's Why Rafael Holdings Is Plummeting Today

A clinical trial failure with the company's lead candidate has investors running for the exits.

Cory Renauer | Oct 28, 2021

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services